OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES Share Price

Certificat

DE000GG1UDW9

Real-time BOERSE MUENCHEN 11:55:38 04/06/2024 pm IST
0.687 EUR +2.08% Intraday chart for OPEN END TURBO OPTIONSSCHEIN LONG - COOPER COMPANIES
Current month+1.78%
1 month+15.46%
Date Price Change
04/24/04 0.687 +2.08%
03/24/03 0.673 -0.30%
31/24/31 0.675 +22.28%
30/24/30 0.552 -4.00%
29/24/29 0.575 -6.05%

Real-time BOERSE MUENCHEN

Last update June 04, 2024 at 11:55 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying THE COOPER COMPANIES, INC.
Issuer Goldman Sachs
WKN GG1UDW
ISINDE000GG1UDW9
Date issued 04/01/2024
Strike 76.25 $
Maturity Unlimited
Parity 25 : 1
Emission price 0.66
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.098
Lowest since issue 0.511

Company Profile

The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Sector
-
More about the company

Ratings for The Cooper Companies, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: The Cooper Companies, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
94.56 USD
Average target price
108.2 USD
Spread / Average Target
+14.38%
Consensus